Although no sex differences have been shown in amyloid-β (Aβ) concentration in CSF nor Aβ positron emission tomography positivity in AD patients22, clinically normal females with higher Aβ burden have been shown to have higher tau levels23 in the entorhinal cortex, one of the most vulnerable brain regions in AD. This evidence concerns the gene MAPT and Alzheimer disease.